Chemical Structure : AR420626
CAS No.: 1798310-55-0
货号: PC-49032Not For Human Use, Lab Use Only.
AR420626 is a potent, selective GPR41/FFA3 agonist with pEC50 of 5.74 in [35S]GTPγS-binding assays, induces apoptosis in HCC cells, including HepG2 and HLE cells.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥980 | In stock | |
10 mg | ¥1580 | In stock | |
25 mg | ¥2780 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AR420626 is a potent, selective GPR41/FFA3 agonist with pEC50 of 5.74 in [35S]GTPγS-binding assays, induces apoptosis in HCC cells, including HepG2 and HLE cells.
AR420626 elicits an extrinsic apoptotic pathway and histone deacetylase inhibition, and inhibits growth of HepG2 xenografts.
AR420626 induces apoptosis via the TNF-α-induced extrinsic apoptotic pathway.AR420626 induces apoptosis via activation of the mammalian target of rapamycin complex 1 (mTORC1) pathway in HepG2 cells.
分子量 | 417.286 | |
分子式 | C21H18Cl2N2O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-(2,5-Dichlorophenyl)-4-(furan-2-yl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxamide |
1. Mikami D, et al. Ther Adv Med Oncol. 2020 Mar 20;12:1758835920913432.
2. Said H, et al. Dig Dis Sci. 2017 Aug;62(8):1944-1952.
3. Brian D Hudson, et al. Mol Pharmacol. 2014 Aug;86(2):200-10.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright